Sign in

NCT07572656Completed

Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia

Comparison of the Efficacy of Intravenous Labetalol and Intravenous Hydralazine for the Treatment of Hypertension in Patients With Severe Preeclampsia.

Source: ClinicalTrials.gov · Last updated 7 May 2026

Brief summary (registry, in English)

Due to limited data regarding preeclampsia from the local population, the debate is still ongoing in the study setting. Hence, the current study was planned to compare the efficacy of labetalol and hydralazine for the treatment of hypertension in patients with severe preeclampsia.

Status (registry)
Completed
Study type
Interventional
Enrollment
132 (actual)
First submitted
1 May 2026
Start date
1 May 2024
Primary completion date
31 Oct 2024
Lead sponsor
Muhammad Aamir Latif
NCT number
NCT07572656

What you commit to

  • Study type: Interventional
  • Participants enrolled: 132
  • From 1 May 2024 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients receiving more than one antihypertensive drug since admission

Other illness

  • Known allergy to hydralazine or labetalol
  • Women with pre-existing hypertension systolic blood pressure ≥130 mmHg, diastolic blood pressure ≥80 mmHg
  • Women with chronic renal failure

Other

  • Deranged liver function tests due to any other cause

Who the study is looking for

  • Pregnant women
  • Both primiparous and multiparous women
  • Aged 20-35 years
  • Gestational age ≥20weeks (assessed on last menstrual period)
  • With severe preeclampsia

Age in the registry: 20 years to 35 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Sadiq Abbasi Hospital
Coordinator of this site? Confirm its status
BahawalpurPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.